2022 ASCO GI Cancers Symposium Keynote: Impact of the COVID-19 Pandemic on Equity and Access to Care

Please Join Us: 2022 Gastrointestinal Cancers SymposiumПодробнее

2022 ASCO GI Cancers Symposium Keynote: Precision Medicine, AI and InnovationПодробнее

Highlights in Urologic Oncology From 2022 ASCO GU Cancers SymposiumПодробнее

Your Invitation to the 2022 Gastrointestinal Cancers SymposiumПодробнее

Dr. Laura Goff and Dr. Mike Gibson on ASCO GI 2022Подробнее

Highlights in GI cancer at ASCO 2022Подробнее

Key updates at ASCO GI 2022Подробнее

2022 ASCO GU Cancers Symposium Keynote | A Path Forward: Addressing Disparities in GU CancersПодробнее

What to look forward to at ASCO GI 2022Подробнее

The impact of COVID-19 on the care of patients with metastatic GU cancersПодробнее

The emerging role of ctDNA in the early diagnosis of GI cancersПодробнее

ASCO COVID 19 and Cancer PresscastПодробнее

GU ASCO Symposium 2022 SummaryПодробнее

Highlights and key clinical trial updates from ASCO GI 2022Подробнее

ASCO GI 2023 highlights: AI in gastrointestinal cancersПодробнее

Dr. Ibrahim Sahin Gives Update on GI Cancers at ASCO 2022Подробнее

GI Oncology at ASCO 2022: Tumor Sidedness, ctDNA, and MRDПодробнее

Celebrating 20 Years: ASCO GI Cancers SymposiumПодробнее

2021 GI ASCO RECAPПодробнее